Nanjing Leads Biolabs Co., Ltd. (09887) published its monthly return for the period ended 28 February 2026, reporting no changes in issued share capital during the month. The total authorized share capital remained at RMB 198.89 million, comprised of 153.28 million H shares listed on The Stock Exchange of Hong Kong and 45.61 million unlisted shares.

According to the announcement, the public float requirement for the H shares has been met. No share options, warrants, or convertible securities were declared, and there were no treasury shares reported.